The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A real-world comparative analysis of cardiovascular (CV) safety and time to next treatment (TTNT) with acalabrutinib versus ibrutinib in treatment-naive patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
 
Daniel Ermann
Consulting or Advisory Role - ADC Therapeutics; Beigene
Speakers' Bureau - AstraZeneca
 
George Dranitsaris
Research Funding - AstraZeneca
 
Sibel Blau
Employment - Northwest Medical Specialties
Leadership - Northwest Medical Specialties; ONCare Alliance, LLC
Stock and Other Ownership Interests - All4cure (I); Northwest Medical Specialties
Honoraria - American Journal of Managed Care; Cardinal Health; Novartis; Puma Biotechnology
Consulting or Advisory Role - Billion to One; IntegraConnect
Research Funding - Northwest Medical Specialties
Expert Testimony - Northwest Medical Specialties
Travel, Accommodations, Expenses - Northwest Medical Specialties; ONCare Alliance, LLC
Other Relationship - All4Cure (I); Exigent Research; Northwest Medical Specialties; ONCare Alliance, LLC
 
Aaron Peevyhouse
Employment - ONCare Alliance, LLC
 
Heather Neuhalfen
Employment - ConcertAI; ONCare Alliance
 
Svea Wahlstrom
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Samantha Thompson
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Anna Teschemaker
Employment - AstraZeneca
 
Vikram Shetty
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Mayuer Narkhede
Honoraria - Abbvie; ADC therapeutics; Astrazeneca; Beigene; Genmab; Kite, a Gilead Company
Consulting or Advisory Role - Abbvie; ADC therapeutics; Astrazeneca; Beigene; Genmab; Kite, a Gilead Company
Speakers' Bureau - Abbvie; Adaptive Biotechnologies; Beigene; Genentech/Roche; Lilly
Research Funding - Abbvie; ADC Therapeutics; Beigene; Cullinan Oncology; EUSA/Recordati diseases; Genmab; Natera
Expert Testimony - Abbvie; ADC therapeutics; Astrazeneca; Beigene; Genmab